Market research
600594.SHG Guizhou Yibai Pharmaceutical Co., Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 3B
- P/E ratio
- Not available
- Analyst target
- 6.55
- Dividend yield
- Not available
- Beta
- 0.14
Community
Investor discussion
1 comment
Sign in to join the 600594.SHG discussion.
5 years, 5 months ago
Guizhou Yibai Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 1.9% above its 200 day moving average.
From a valuation standpoint, the stock is 86.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.3.
Guizhou Yibai Pharmaceutical Co., Ltd's total revenue rose by 6.8% to $960M since the same quarter in the previous year.
Its net income has increased by 28.8% to $70M since the same quarter in the previous year.
Finally, its free cash flow fell by 522.4% to $-105M since the same quarter in the previous year.
Based on the above factors, Guizhou Yibai Pharmaceutical Co., Ltd gets an overall score of 4/5.